|
Volumn 36, Issue 2 SUPPL., 2004, Pages S331-S336
|
Use of cyclosporine in thoracic transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CYCLOSPORIN A;
DACLIZUMAB;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ANASTOMOSIS DEHISCENCE;
BRONCHIAL ANASTOMOTIC DEHISCENCE;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG CHOICE;
DRUG FORMULATION;
DRUG MONITORING;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG USE;
GINGIVA HYPERPLASIA;
GRAFT REJECTION;
HEADACHE;
HEALTH CARE COST;
HEART TRANSPLANTATION;
HIRSUTISM;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNE DEFICIENCY;
IMMUNOSUPPRESSIVE TREATMENT;
INTERSTITIAL NEPHRITIS;
LIVER DYSFUNCTION;
LUNG TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MICROEMULSION;
NEPHROTOXICITY;
NEUROTOXICITY;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
SIDE EFFECT;
SURVIVAL;
THORAX SURGERY;
TRANSPLANTATION;
TREMOR;
VASCULAR DISEASE;
|
EID: 1642368961
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.01.024 Document Type: Article |
Times cited : (13)
|
References (63)
|